Regulation of matrix proteins and impact on vascular structure

Current Hypertension Reports

Volumn 2, Issue 1, 2000, Pages 106-113

  Tuñón, José ^a   Ruiz Ortega, Marta ^a   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; COLLAGEN; ENDOTHELIN; PROTEOGLYCAN; SCLEROPROTEIN;

ARTERIOSCLEROSIS; HUMAN; HYPERTENSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THROMBOSIS;

ARTERIOSCLEROSIS; BRADYKININ; COLLAGEN; ENDOTHELINS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYPERTENSION; PROTEOGLYCANS; RENIN-ANGIOTENSIN SYSTEM; THROMBOSIS;

EID: 0034136007     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0067-2     Document Type: Article

References (53)

1. Raghvendra KD, Jackson EK, Rupprecht HD, Sterzel RB: Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens 1997, 6:88-105.
2. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
3. Sukhova GK, Schonbeck U, Rabkin E, et al.: Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
4. Shah PK, Falk E, Badimon JJ, et al.: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
5. Aikawa M, Rabkin E, Okada Y, et al.: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. Circulation 1998, 97:2433-2444.
6. Bustos C, Hernández-Presa MA, Ortego M, et al.: HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998, 32:2057-2064.
7. Barnes PJ, Karin M: Nuclear factor kB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071
8. Yokoo T, Kitamura M: Dual regulation of IL 1 beta mediated matrix metalloproteinase 9 expression in mesangial cells by NF kappa B and AP-1. Am J Physiol 1996, 270:F123-F130.
9. Shih PT, Elices MJ, Fang ZT, et al: Minimally modified low density lipoprotein induces monocyte adhesion to endothelial connecting segment 1 by activating beta1 integrin. J Clin Invest 1999, 103:613-625.
10. Wesley RB, Meng X, Godin D, Galis ZS: Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol 1998, 18:432-440.
11. Weitkamp B, Cullen P, Plenz G, et al.: Human macrophages synthesize type VIII collagen in vitro and in the athero sclerotic plaque. FASEB J 1999, 13:1445-1457.
12. Fitzsimmons C, Proudfoot D, Bowyer DE: Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: implications for plaque stability. Atherosclerosis 1999, 142:287-293.
13. Bachem MG, Wendelin D, Schneiderhan W, et al.: Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells. Clin Chem Lab Med 1999, 37:319-326.
14. Matsubara H: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998, 83:1182-1191.
15. Ruiz-Ortega M, Gómez-Garre D, Alcazar R, et al.: Involvement of angiotensin II and endothelin on matrix protein produc tion and renal sclerosis. J Hypertens 1994, 12:S51-S58.
16. Egido J: Vasoactive hormones and renal sclerosis (Nephrology Forum). Kidney Int 1996, 49:578-597.
17. Hsueh WA, Do YS, Anderson PW, Law RE: Angiotensin II in cell growth and matrix production. Adv Exp Med Biol 1995, 377:217-223.
18. Border WA, Ruoslahti E: Transforming growth factor β in disease: The dark side of tissue repair. J Clin Invest 1992, 90:1-7.
19. Ruiz-Ortega M, González S, Seron D, et al: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 1995, 48:1778-1791.
20. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet-derived growth factor A chain and c myc gene expressions by angio tensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1419-1424.
21. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs hyperplasia. J Clin Invest 1992, 90:456-461.
22. Sudhir K, Wilson E, Chatterjee K, Ives HE: Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 1993, 92:3003-3007.
23. Powell JS, Clozel JP, Müller R K M, et al: Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 1989, 245:186-188.
24. Hernández-Presa M, Bustos C, Ortego M, et al: Angiotensin converting enzyme inhibition prevents arterial NF kB activa tion, MCP 1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997, 95:1532-1541.
25. Hernández-Presa MA, Bustos C, Ortego M, et al: The ACE inhibitor quinapril reduces the arterial expression of NF kB depen dent proinflammatory factors but not of collagen in a rabbit model of atherosclerosis. Am J Pathol 1998, 153:1825-1837.
26. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of angiotensin converting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. N Engl J Med 2000, in press.
27. Oemar BS, Werner A, Garnier JM, et al.: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997, 95:831-839.
28. Hishikawa K, Oemar BS, Tanner FC, et al.: Overexpression o connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999, 100:2108-2112.
29. Farb A, Burke AP, Tang AL, et al.: Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996, 93:1354-1363.
30. Chrysant SG: Vascular remodeling: the role of angiotensin-converting enzyme inhibitors. Am Heart J 1998, 135:S21-S30.
31. Blacher J, Guerin AP, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
32. Paul M, Wagner J, Dzau VJ: Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 1993, 91:2058-2064.
33. McEwan PE, Gray GA, Sherry L, et al.: Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 1998, 98 2765-2773.
34. Boffa JJ, Tharaux PL, Placier S, et al.: Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. Circulation 1999, 100:1901-1908.
35. Funck RC, Wilke A, Rupp H, Brilla CG: Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease. Adv Exp Med Biol 1997, 432:35-44.
36. Ruiz-Ortega M, Egido J: Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997, 52:1497-1510.
37. Gómez-Garre D, Ruiz-Ortega M, Ortego M, et al.: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996, 27:885-892.
38. Ruiz-Ortega M, Lorenzo O, Egido J: Angiotensin III up-regu-lates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. Kidney Int 1998, 68:S41-S45.
39. Kerins DM, Hao Q, Vaughan DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995, 96:2515-2520.
40. Brasier AR, Li J: Mechanisms for inducible control of angio-tensinogen gene transcription. Hypertension 1996, 27:465-475.
41. Zimmermann R, Kastens J, Linz W, et al.: Effect of long-term inhibition on myocardial tissue in hypertensive stroke-prone rats. J Mol Cell Cardiol 1999, 31:1447-1456.
42. Varo N, Etayo JC, Zalba G, et al.: Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1999, 17:107-114.
43. Brown L, Duce B, Miric G, Sernia C: Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol 1999, 10(Suppl 1):S143-S148.
44. Ledingham JM, Laverty R: Renal afferent arteriolar structure in the genetically (GH) hypertensive rat and the ability of losar-tan and enalapril to cause structural remodeling. J Hypertens 1998, 16:1945-1952.
45. Pechanova O, Bernatova I, Pelouch V, Simko F: Protein remodeling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 1997, 3365-3374.
46. Laviades C, Varo N, Fernández J, et al.: Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998, 98:535-540.
47. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction. Hypertension 1991, 543-549.
48. Chatziantoniou C, Boff JJ, Ardaillou R, Dussaule JC: Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. J Clin Invest 1998, 101:2780-2789.
49. Hocher B, George I, Rebstock J, et al.: Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension 1999, 33:816-822.
50. Lewin ER: Endothelins as cardiovascular peptides. Nephron 1996, 16:246-251.
51. Gallagher AM, Yu H, Printz MP: Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 1998, 32:84-88.
52. Partovian C, Benetos A, Pommies JP, et al.: Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol 1998, 274:H1423-H1428.
53. Benetos A, Levy BI, Lacolley P, et al.: Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997, 17:3196-3201.